QT
PTCT icon

Quantamental Technologies’s PTC Therapeutics PTCT Stock Holding History

Quantamental Technologies’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,403
Closed -$372K – 621
2022
Q3 		$372K Buy
+7,403
New +$363K 0.14% 250
2020
Q1 		– Sell
-6,714
Closed -$322K – 336
2019
Q4 		$322K Buy
+6,714
New +$285K 0.17% 233
2019
Q3 		– Sell
-1,093
Closed -$49K – 1768
2019
Q2 		$49K Buy
+1,093
New +$43.2K 0.02% 909

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Quantamental Technologies's PTCT Position: Q4 2022 in Review

Quantamental Technologies sold out of PTC Therapeutics (PTCT) in Q4 2022, closing a stake of 7,403 shares — an estimated $372K sold.

Quantamental Technologies first reported a position in PTCT in Q2 2019 and held it in 3 quarters. The position peaked at $372K in Q3 2022. 202 funds tracked by Wall St. Rank hold PTCT as of Q4 2022.

  • Quantamental Technologies reported no remaining PTC Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 7,403 PTC Therapeutics shares in Q4 2022, an estimated $372K.
  • Quantamental Technologies first reported a position in PTC Therapeutics in Q2 2019 and held it in 3 quarters.
  • Quantamental Technologies's PTC Therapeutics position peaked at $372K in Q3 2022.
  • 202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.